AJTMH ASTMH MEMBERSHIP INFORMATION: astmh@astmh.org
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 14(3), 1965, pp. 343-353
Copyright © 1965 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thompson, P. E.
Right arrow Articles by Waitz, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thompson, P. E.
Right arrow Articles by Waitz, J. A.

Laboratory Studies on the Repository Antimalarial Activity of 4,4'-Diacetylaminodiphenylsulfone, Alone and Mixed with Cycloguanil Pamoate (CI-501)

Paul E. Thompson, Bronislawa Olszewski AND J. Allan Waitz
Research Division, Parke, Davis & Company, Ann Arbor, Michigan

In a continuing effort to develop repository antimalarials that would be effective against both normal and drug-resistant parasites, 4,4'-diacetylaminodiphenylsulfone (DADDS) was studied alone and mixed with cycloguanil pamoate. Trophozoite-induced infections of Plasmodium berghei and of P. cynomolgi were used in mice and rhesus monkeys. The drugs were given subcutaneously to mice and intramuscularly to monkeys, as either aqueous or lipid suspensions.

DADDS had varying degrees of prolonged action in mice: a dose of 100 to 400 mg/kg almost invariably prevented or greatly suppressed patent infections through 6 to 14 weeks.

A 50 mg/kg dose of DADDS prevented patent infections in monkeys for 63–268 (average 158) days and greatly suppressed the parasitemia for many weeks longer.

In therapeutic tests against established patent infections in monkeys, DADDS suppressed the parasitemia slowly.

There were indications that DADDS was slowly released from the injection site and led to low blood levels of active moiety over prolonged periods. The drug was well tolerated locally and systemically by gross examination.

In the prevention of patent infections in monkeys, DADDS and cycloguanil pamoate (of comparable particle sizes) protected for similar periods of time and a 1:1 mixture protected as long as an equivalent amount of either drug alone.

DADDS, cycloguanil pamoate, and a 1:1 mixture were compared against lines of P. berghei highly resistant to either diaminodiphenylsulfone or to the dihydrotriazine moiety of cycloguanil pamoate. The mixture had broader repository action against the drug-resistant lines than did either drug alone.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1965 by the American Society of Tropical Medicine and Hygiene.